Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0151 | 0.0205 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0151 | 0.0205 | 0.5 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0388 | 0.2566 | 0.3016 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.0281 | 0.1492 | 1 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0151 | 0.0205 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1134 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1134 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0239 | 0.1075 | 0.1263 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0151 | 0.0205 | 0.5 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0984 | 0.8508 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0151 | 0.0205 | 0.5 |
Onchocerca volvulus | Putative sulfate transporter | 0.0207 | 0.0755 | 0.5 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0151 | 0.0205 | 0.5 |
Schistosoma mansoni | carbonic anhydrase | 0.0281 | 0.1492 | 1 |
Leishmania major | carbonic anhydrase family protein, putative | 0.0281 | 0.1492 | 1 |
Echinococcus granulosus | carbonic anhydrase II | 0.0151 | 0.0205 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0981 | 0.8472 | 0.8204 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0981 | 0.8472 | 0.8204 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0151 | 0.0205 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0151 | 0.0205 | 0.5 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0912 | 0.7783 | 0.9148 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.0281 | 0.1492 | 0.5 |
Onchocerca volvulus | 0.0207 | 0.0755 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.